Patent · US Active

Gpr177 as target and marker in tumors

US9062114B2 · kind B2 · utility

0Cited by

4References

9Claims

0Family size

Assignees

Deutsches Krebsforschungszentrum · DE
RUPRECHT - KARLS - UNIVERSITÄT HEIDELBERG · DE

Inventors

Michael Boutros · Heidelberg, DE
Iris Augustin · Dossenheim, DE

Key dates

Filing date	Apr 18, 2012
Grant date	Jun 23, 2015
Priority date	—
Expiry date	Apr 18, 2032

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/726
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to modulators of G protein-coupled receptor 177 (Gpr177) for use in the treatment, alleviation, prevention and/or diagnosis of cancer as well as to methods for the diagnosis of such cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.